These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8253154)
21. Trypanosoma cruzi surface molecule gp90 downregulates invasion of gastric mucosal epithelium in orally infected mice. Cortez M; Silva MR; Neira I; Ferreira D; Sasso GR; Luquetti AO; Rassi A; Yoshida N Microbes Infect; 2006 Jan; 8(1):36-44. PubMed ID: 16153873 [TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies to metacyclic stage antigens of Trypanosoma cruzi. Chao D; Dusanic DG Am J Trop Med Hyg; 1985 Jul; 34(4):694-701. PubMed ID: 3927760 [TBL] [Abstract][Full Text] [Related]
23. Characterization of a cDNA clone encoding the carboxy-terminal domain of a 90-kilodalton surface antigen of Trypanosoma cruzi metacyclic trypomastigotes. Franco FR; Paranhos-Bacallà GS; Yamauchi LM; Yoshida N; da Silveira JF Infect Immun; 1993 Oct; 61(10):4196-201. PubMed ID: 8406808 [TBL] [Abstract][Full Text] [Related]
24. Trypanosoma cruzi: immunity-induced in mice and rats by trypomastigote excretory-secretory antigens and identification of a peptide sequence containing a T cell epitope with protective activity. Taibi A; Plumas-Marty B; Guevara-Espinoza A; Schöneck R; Pessoa H; Loyens M; Piras R; Aguirre T; Gras-Masse H; Bossus M J Immunol; 1993 Sep; 151(5):2676-89. PubMed ID: 7689612 [TBL] [Abstract][Full Text] [Related]
25. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161 [TBL] [Abstract][Full Text] [Related]
26. Role of GP82 in the selective binding to gastric mucin during oral infection with Trypanosoma cruzi. Staquicini DI; Martins RM; Macedo S; Sasso GR; Atayde VD; Juliano MA; Yoshida N PLoS Negl Trop Dis; 2010 Mar; 4(3):e613. PubMed ID: 20209152 [TBL] [Abstract][Full Text] [Related]
27. Structural basis of the interaction of a Trypanosoma cruzi surface molecule implicated in oral infection with host cells and gastric mucin. Cortez C; Yoshida N; Bahia D; Sobreira TJ PLoS One; 2012; 7(7):e42153. PubMed ID: 22860068 [TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of Trypanosoma cruzi infection by oral route. Yoshida N Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():101-7. PubMed ID: 19753464 [TBL] [Abstract][Full Text] [Related]
29. Comparative studies on epimastigote and metacyclic stages of Trypanosoma cruzi. II. Selective lysis by rodent sera. Chao D; Hsu YP; Chan CH; Chen YA Int J Zoonoses; 1985 Dec; 12(4):323-30. PubMed ID: 3939135 [TBL] [Abstract][Full Text] [Related]
30. Resistance to acute Trypanosoma cruzi infection resulting from immunization of mice with a 90-kilodalton antigen from metacyclic trypomastigotes. González J; Araguth MF; Yoshida N Infect Immun; 1991 Mar; 59(3):863-7. PubMed ID: 1900064 [TBL] [Abstract][Full Text] [Related]
31. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model. Wallace A; Sanchez G; Venegas J; Solari A Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829 [TBL] [Abstract][Full Text] [Related]
33. Genetic structure and expression of the surface glycoprotein GP82, the main adhesin of Trypanosoma cruzi metacyclic trypomastigotes. Correa PR; Cordero EM; Gentil LG; Bayer-Santos E; da Silveira JF ScientificWorldJournal; 2013; 2013():156734. PubMed ID: 23431251 [TBL] [Abstract][Full Text] [Related]
34. Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection. Boscardin SB; Kinoshita SS; Fujimura AE; Rodrigues MM Infect Immun; 2003 May; 71(5):2744-57. PubMed ID: 12704149 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease. Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671 [TBL] [Abstract][Full Text] [Related]
36. Trypanosoma cruzi metacyclic trypomastigotes: neutralization by the stage-specific monoclonal antibody 1G7 and immunogenicity of 90 kD surface antigen. Araguth MF; Rodrigues MM; Yoshida N Parasite Immunol; 1988 Nov; 10(6):707-12. PubMed ID: 3146050 [TBL] [Abstract][Full Text] [Related]
37. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies. Almeida IC; Milani SR; Gorin PA; Travassos LR J Immunol; 1991 Apr; 146(7):2394-400. PubMed ID: 1706399 [TBL] [Abstract][Full Text] [Related]
38. Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' disease. Affranchino JL; Ibañez CF; Luquetti AO; Rassi A; Reyes MB; Macina RA; Aslund L; Pettersson U; Frasch AC Mol Biochem Parasitol; 1989 May; 34(3):221-8. PubMed ID: 2499788 [TBL] [Abstract][Full Text] [Related]
39. Further evaluation of lectin affinity purified glycoprotein (GP90) in the enzyme linked immunosorbent assay (ELISA) for diagnosis of Trypanosoma cruzi infection. Schechter M; Luquetti AO; Rezende JM; Rassi A; Miles MA Trans R Soc Trop Med Hyg; 1985; 79(5):637-40. PubMed ID: 3938088 [TBL] [Abstract][Full Text] [Related]
40. Posttranscriptional mechanisms involved in the control of expression of the stage-specific GP82 surface glycoprotein in Trypanosoma cruzi. Gentil LG; Cordero EM; do Carmo MS; dos Santos MR; da Silveira JF Acta Trop; 2009 Feb; 109(2):152-8. PubMed ID: 19013421 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]